Mindray Medical: The profit margin for 2026 is expected to decrease slightly, but the rate of decrease will significantly narrow.

On April 17, Mindray Medical expressed at the performance conference that in 2026, with the implementation of the centralized procurement of tumor markers and reagent kits, it is expected that the gross profit margin will be slightly affected. At the same time, according to the global minimum tax rules established by various countries, Mindrays effective tax rate should not be lower than 15%, as well as potential exchange losses due to the depreciation of the US dollar. Taking these factors into consideration, it is anticipated that the profit margin in 2026 will slightly decrease, but the extent of the decrease will be significantly narrowed.